A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis

Autor: Karen Woo, Ellen S. Regalado, Dianna M. Milewicz, Devin S. Zarkowsky, Giovanni De Caridi, Frank M. Davis, Melanie Pepin, Erin M. Miller, Richard J. Powell, Kristofer M. Charlton-Ouw, Kelli L. Hicks, K. Nicole Weaver, Christian-Alexander Behrendt, Sherene Shalhub, Maurício Serra Ribeiro, Dawn M. Coleman, Gustavo S. Oderich, Cole Nishikawa, Peter F. Lawrence, Katie E. Shean, E. Sebastian Debus, Yskert von Kodolitsch, Peter H. Byers, Marc L. Schermerhorn
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
DNA Mutational Analysis
Disease
030204 cardiovascular system & hematology
0302 clinical medicine
Risk Factors
Germany
Vascular genetic testing
030212 general & internal medicine
Family history
medicine.diagnostic_test
Middle Aged
Prognosis
Vascular Ehlers-Danlos syndrome
Phenotype
Italy
Cohort
Female
Cardiology and Cardiovascular Medicine
Adult
medicine.medical_specialty
Adolescent
COL3A1 mutation
Heritable arteriopathies
Risk Assessment
Article
Diagnosis
Differential

03 medical and health sciences
Young Adult
Predictive Value of Tests
Internal medicine
medicine
Humans
Genetic Predisposition to Disease
Genetic testing
Retrospective Studies
business.industry
Retrospective cohort study
medicine.disease
United States
Collagen Type III
Cross-Sectional Studies
Ehlers–Danlos syndrome
Clinical diagnosis
Skin biopsy
Mutation
COL3A1 mutation
Heritable arteriopathies
Vascular Ehlers-Danlos syndrome
Vascular genetic testing

Surgery
Ehlers-Danlos Syndrome
business
Zdroj: J Vasc Surg
Popis: OBJECTIVE. Vascular Ehlers-Danlos syndrome (vEDS) is a rare disorder and one of 13 types of Ehlers-Danlos syndrome (EDS). The syndrome results in aortic and arterial aneurysms and dissections at a young age. Diagnosis is confirmed with molecular testing via skin biopsy or genetic testing for COL3A1 pathogenic variants. We describe a multi-institutional experience in the diagnosis of vEDS from 2000 to 2015. METHODS. This is a multi-institutional cross-sectional retrospective study of individuals with vEDS. The institutions were recruited through the Vascular Low Frequency Disease Consortium. Individuals were identified using the International Classification of Diseases (ICD)-9 and 10-CM codes for EDS (756.83 and Q79.6). Review of records was then performed to select individuals with vEDS. Data abstraction included demographics, family history, clinical features, major and minor diagnostic criteria, and molecular testing results. Individuals were classified into two cohorts and then compared: those with pathogenic COL3A1 variants and those diagnosed by clinical criteria alone without molecular confirmation. RESULTS. Eleven institutions identified 173 (35.3% male, 56.6% Caucasian) individuals with vEDS. Of those, 11 (9.8%) had non-pathogenic alterations in COL3A1 and were excluded from the analysis. Among the remaining individuals, 86 (47.7% male, 68% Caucasian, 48.8% positive family history) had pathogenic COL3A1 variants and 76 (19.7% male, 19.7% Caucasian, 43.4% positive family history) were diagnosed by clinical criteria alone without molecular confirmation. Compared to the cohort with pathogenic COL3A1 variants, the clinical diagnosis only cohort had a higher number of females (80.3% vs. 52.3%, P
Databáze: OpenAIRE